Rate of insulin infusion with a minipump required to maintain a normoglycemia in diabetic rats
- PMID: 6338503
- DOI: 10.3181/00379727-172-41529
Rate of insulin infusion with a minipump required to maintain a normoglycemia in diabetic rats
Abstract
It is notoriously difficult to normalize plasma glucose profiles for a prolonged time by conventional methods of insulin administration in both human and animal diabetics. The present study was conducted to determine the dosage of insulin needed to maintain prolonged and around-the-clock normoglycemia as well as normoglucagonemia in streptozotocin diabetic rats with the Alzet osmotic minipump which releases insulin constantly for 14 days. A minipump was inserted into the peritoneal cavity of diabetic rats under chloral hydrate anesthesia. Diabetic rats were treated with several consecutive minipumps and body weights, plasma glucose, and plasma glucagon levels were monitored. Plasma glucose concentrations were determined every 8 hr for several days and were found essentially identical during the active life of the minipump. An average insulin dose of 8.0 to 9.0 U/kg/day was required to normalize body weights, plasma glucose, and plasma glucagon of streptozotocin diabetic rats treated with the Alzet osmotic minipump Model 2002.
Similar articles
-
Long-term treatment of streptozotocin-induced diabetes by continuous insulin minipump in the Syrian hamster.Cell Transplant. 1999 Sep-Oct;8(5):561-5. doi: 10.1177/096368979900800511. Cell Transplant. 1999. PMID: 10580350
-
Effect of prolonged insulin treatment on blunted plasma catecholamine and glucagon increase during insulin hypoglycemia in streptozotocin diabetic rats.Metabolism. 1983 Apr;32(4):377-82. doi: 10.1016/0026-0495(83)90047-1. Metabolism. 1983. PMID: 6353141
-
Continuous long-term insulin delivery in diabetic rats utilizing implanted osmotic minipumps.J Pharmacol Methods. 1983 Feb;9(1):71-5. doi: 10.1016/0160-5402(83)90052-9. J Pharmacol Methods. 1983. PMID: 6843141
-
The effect of continuous subcutaneous insulin infusion therapy on morphological and biochemical abnormalities of peripheral nerves in experimental diabetes.J Neurol Sci. 1986 Jun;74(1):55-67. doi: 10.1016/0022-510x(86)90191-7. J Neurol Sci. 1986. PMID: 3522807
-
Superactive somatostatin analog decreases plasma glucose and glucagon levels in diabetic rats.Peptides. 1988 May-Jun;9(3):561-5. doi: 10.1016/0196-9781(88)90164-7. Peptides. 1988. PMID: 2901737
Cited by
-
Correction of abnormal small intestinal cytosolic protein kinase C activity in streptozotocin-induced diabetes by insulin therapy.Biochem J. 1990 Dec 15;272(3):653-8. doi: 10.1042/bj2720653. Biochem J. 1990. PMID: 2176470 Free PMC article.
-
Insulin exerts metabolic and growth-promoting effects by a direct action on the liver in vivo: clarification of the functional significance of the portal vascular link between the beta cells of the pancreatic islets and the liver.Proc Natl Acad Sci U S A. 1987 Oct;84(20):7300-4. doi: 10.1073/pnas.84.20.7300. Proc Natl Acad Sci U S A. 1987. PMID: 3313390 Free PMC article.
-
Reduced insulin-like growth factor-I mRNA content in liver, adrenal glands and spinal cord of diabetic rats.Diabetologia. 1994 Nov;37(11):1073-81. doi: 10.1007/BF00418370. Diabetologia. 1994. PMID: 7532599
-
Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose.J Clin Invest. 1989 May;83(5):1667-75. doi: 10.1172/JCI114066. J Clin Invest. 1989. PMID: 2708528 Free PMC article.
-
Correction of enhanced Na(+)-H+ exchange of rat small intestinal brush-border membranes in streptozotocin-induced diabetes by insulin or 1,25-dihydroxycholecalciferol.J Clin Invest. 1991 May;87(5):1755-62. doi: 10.1172/JCI115194. J Clin Invest. 1991. PMID: 1850761 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical